CLINICAL_TRIALS
trial_result
· 2025-10-29
Clinical Trial Update: A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones [Phase 2]
Summary
A Phase 2a study of LLX-424 in patients with a history of nephrolithiasis (kidney stones) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lilac Therapeutics, Inc. | Conditions: Kidney Stones | Phase 2 | Status: COMPLETED